Search

Your search keyword '"BARRON, F"' showing total 245 results
Start Over Author "BARRON, F"
245 results on '"BARRON, F"'

2. Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors

Author

Rojas, L., Mayorga, D., Ruiz-Patiño, A., Rodríguez, J., Cardona, A.F., Archila, P., Avila, J., Bravo, M., Ricaurte, L., Sotelo, C., Arrieta, O., Zatarain-Barrón, Z.L., Carranza, H., Otero, J., Vargas, C., Barrón, F., Corrales, L., Martín, C., Recondo, G., Pino, L.E., Bermudez, M.A., Gamez, T., Ordoñez-Reyes, C., García-Robledo, J.E., de Lima, V.C., Freitas, H., Santoyo, N., Malapelle, U., Russo, A., Rolfo, C., and Rosell, R.

Published
2022
Full Text
View/download PDF

5. Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program

Author

González-Cao, M., Arance, A., Piulats, J. M., Marquez-Rodas, I., Manzano, J. L., Berrocal, A., Crespo, G., Rodriguez, D., Perez-Ruiz, E., Berciano, M., Soria, A., Castano, A. G., Espinosa, E., Montagut, C., Alonso, L., Puertolas, T., Aguado, C., Royo, M. A., Blanco, R., Rodríguez, J. F., Muñoz, E., Mut, P., Barron, F., Martin-Algarra, S., and Spanish Melanoma Group

Published
2017
Full Text
View/download PDF

17. Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group

Author

Arrieta, O, Cardona, AF, Lara-Mejia, L, Heredia, D, Barron, F, Zatarain-Barron, ZL, Lozano, F, de Lima, VC, Maldonado, F, Corona-Cruz, F, Ramos, M, Cabrera, L, Martin, C, Corrales, L, Cuello, M, Arroyo-Hernandez, M, Aman, E, Bacon, L, Baez, R, Benitez, S, Botero, A, Burotto, M, Caglevic, C, Ferraris, G, Freitas, H, Kaen, DL, Lamot, S, Lyons, G, Mas, L, Mata, A, Mathias, C, Munoz, A, Patane, AK, Oblitas, G, Pino, L, Raez, LE, Remon, J, Rojas, L, Rolfo, C, Ruiz-Patino, A, Samtani, S, Viola, L, Viteri, S, and Rosell, R

Subjects
Health systems, Personal protective equipment, COVID-19, Thoracic oncology, Lung cancer, Recommendations
Abstract

The world currently faces a pandemic due to SARS-CoV-2. Relevant information has emerged regarding the higher risk of poor outcomes in lung cancer patients. As such, lung cancer patients must be prioritized in terms of prevention, detection and treatment. On May 7th, 45 experts in thoracic cancers from 11 different countries were invited to participate. A core panel of experts regarding thoracic oncology care amidst the pandemic gathered virtually, and a total of 60 initial recommendations were drafted based on available evidence, 2 questions were deleted due to conflicting evidence. By May 16th, 44 experts had agreed to participate, and voted on each of the 58 recommendation using a Delphi panel on a live voting event. Consensus was reached regarding the recommendations (> 66 % strongly agree/agree) for 56 questions. Strong consensus (> 80 % strongly agree/agree) was reached for 44 questions. Patients with lung cancer represent a particularly vulnerable population during this time. Special care must be taken to maintain treatment while avoiding exposure.

Published
2020

18. Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries

Author

Cardona, AF, Arrieta, O, Ruiz-Patino, A, Sotelo, C, Zamudio-Molano, N, Zatarain-Barron, ZL, Ricaurte, L, Raez, L, Alvarez, MPP, Barron, F, Rojas, L, Rolfo, C, Karachaliou, N, Molina-Vila, MA, and Rosell, R

Subjects
precision medicine, tropomyosin receptor kinase family, larotrectinib, NTRK
Abstract

Precision oncology is the field that places emphasis on the diagnosis and treatment of tumors that harbor specific genomic alterations susceptible to inhibition or modulation. Although most alterations are only present in a minority of patients, a substantial effect on survival can be observed in this subgroup. Mass genome sequencing has led to the identification of a specific driver in the translocations of the tropomyosin receptor kinase family (NTRK) in a subset of rare tumors both in children and in adults, and to the development and investigation of Larotrectinib. This medication was granted approval by the US Food and Drug Administration for NTRK-positive tumors, regardless of histology or age group, as such, larotrectinib was the first in its kind to be approved under the premise that molecular pattern is more important than histology in terms of therapeutic approach. It yielded significant results in disease control with good tolerability across a wide range of diseases including rare pediatric tumors, salivary gland tumors, gliomas, soft-tissue sarcomas, and thyroid carcinomas. In addition, and by taking different approaches in clinical trial design and conducting allocation based on biomarkers, the effects of target therapies can be isolated and quantified. Moreover, and considering developing nations and resource-limited settings, precision oncology could offer a tool to reduce cancer-related disability and hospital costs. In addition, developing nations also present patients with rare tumors that lack a chance of treatment, outside of clinical trials. This, in turn, offers the possibility for international collaboration, and contributes to employment, education, and health service provisions. The reviews of this paper are available via the supplemental material section.

Published
2020

21. Immunotherapy at Any Line Improves Survival in Hispanic Patients with Advanced Metastatic NSCLC Compared to Chemotherapy (Quijote-CLICaP)

Author

Cardona, AF, Ruiz-Patino, A, Arrieta, OG, Martin, C, Raez, L, Barron, ZLZ, Barron, F, Ricaurte, L, Bravo-Garzon, MA, Mas, L, Corrales, L, Rojas, LL, Lupinacci, L, Perazzo, F, Bas, C, Carranza, O, Puparelli, C, Rizzo, M, Ruiz, R, Rolfo, C, Archila, P, Rodriguez, J, Sotelo, C, Vargas, C, Carranza, H, Otero, J, Pino, L, Ortiz, C, Laguado, P, and Rosell, R

Subjects
Inmunooncology, Chemotherapy, Non small cell lung cancer
Published
2019

27. Cracking the Medicare Secondary Payer Enigma Code

Author

Barron F, Dickinson

Subjects
Insurance Claim Review, Medicaid, Insurance, Health, Reimbursement, Humans, Liability, Legal, History, 20th Century, Medicare, Centers for Medicare and Medicaid Services, U.S, Children's Health Insurance Program, United States
Published
2018

28. Stereotactic Ablative Radiation Therapy Improves Progression-free Survival and Local Control In Patients with Oligometastatic Lung Cancer

Author

Blake, M., primary, Maldonado, F., additional, De la Mata, D., additional, Gerson, R., additional, Flores, F., additional, Barron, F., additional, Butler, E.B., additional, Teh, B.S., additional, Pino, R., additional, Hernandez-Bojorquez, M., additional, Corona, F., additional, Flores, D., additional, and Arrieta, O., additional

Published
2018
Full Text
View/download PDF

29. P1.01-03 Effect of Prophylactic Cranial Irradiation on Cognitive Function and QoL in NSCLC Patients at High Risk of Brain Metastases

Author

Gonzalez-Ling, A., primary, Maldonado, F., additional, Salinas Padilla, M., additional, Arguelles, M., additional, Ramírez-Tirado, L., additional, Zatarain-Barrón, Z., additional, Barron, F., additional, Cabrera-Miranda, L.A., additional, Flores, D., additional, Cardona, A., additional, and Arrieta, O., additional

Published
2018
Full Text
View/download PDF

33. MA25.10 Complete Response by PET-CT After Radical Treatment in Oligometastatic Non-Small Cell Lung Cancer Predicts Longer Survival

Author

Cabrera-Miranda, L.A., primary, Barron, F., additional, Zatarain-Barrón, Z., additional, Ramírez-Tirado, L., additional, Salinas Padilla, M., additional, Corona-Cruz, J., additional, Cardona, A., additional, Arguelles, M., additional, Maldonado, F., additional, Blake, M., additional, Jiménez-Fuentes, E., additional, Aren, O., additional, and Arrieta, O., additional

Published
2018
Full Text
View/download PDF

40. SMARTS and SMARTER: improved simple methods for multiattribute utility measurement

Author

Edwards, Ward and Barron, F. Hutton

Subjects
Multiple criteria decision making -- Methods, Business, Business, general, Human resources and labor relations, Psychology and mental health
Abstract

Simple Multi-attribute Rating Technique (SMART), a multiattribute utility measurement method, has been upgraded into the SMART using Swings (SMARTS) and SMART Exploiting Ranks (SMARTER) methods. SMARTS uses linear approximations to single-dimension utility functions, swing weights and an additive aggregation model. SMARTER also uses SMARTS procedures although it omits the last of two elicitation steps in swing weights. SMARTER performs 98% better than SMARTS without requiring complex judgments.

Published
1994

41. Axiomatic and Numerical Conjoint Measurement: An Evaluation of Diagnostic Efficacy.

Author

Emery, Douglas R. and Barron, F. Hutton

Abstract

There are two complementary approaches to conjoint measurement: axiomatic and numerical. In this article, synthetic data are used to examine how well axiomatic and conjoint measurement methods, individually and comparatively, recover parameters from data with three dimensions. (JKS)

Published
1979

44. Validity of a revised System for Observing Fitness Instruction Time (SOFIT)

Author

Pope RP, Coleman KJ, Gonzalez EC, Barron F, and Heath EM

Abstract

This study was designed to validate the System for Observing Fitness Instruction Time (SOFIT5) and a modified SORT scale (SOFIT6) for assessing activity levels in physical education (PE) classes. Participants were 56 third- to fifth-grade students from a predominantly (98%) Hispanic school. Inter-rater reliability, using intraclass correlations, for both SOFIT5 and SOFIT5 was r = .98. The correlation for the SOFIT5 with TriTrac was r = .60 (CI = .43-.734) and the correlation for the SOFIT6 with TriTrac was r = .68 (CI = .524-.804). A six-point SOFIT scale may be more sensitive to measuring variations in light and moderate physical activity during PE classes as compared to the standard five point SOFIT scale. This has important implications for using this observation system to estimate the effects of interventions for physical activity during PE classes. [ABSTRACT FROM AUTHOR]

Published
2002
Full Text
View/download PDF

50. P2.23 Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy

Author

Arrieta, O., Ruiz-Patiño, A., Cardona, A.F., Martín, C., Raez, L., Barron, L. Zatarain, Barrón, F., Ricaurte, L., Bravo-Garzón, M.A., Mas, L., Corrales-Rodriguez, L., Rojas, L., Lupinacci, L., Perazzo, F., Bas, C., Carranza, O., Pupareli, C., Rizzo, M., Mendoza, R. Ruiz, Rolfo, C.D., Archila, P., Rodríguez, J., Sotelo, C., Vargas, C., Carranza, H., Otero, J., Pino, L.E., Ortíz, C., Laguado, P., and Rosell, R.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results